Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atypical Endometrial Hyperplasia and Endometrial Cancer”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableLooking for participantsNCT05051722
What this trial is testing

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Who this might be right for
Endometrial CancerCervical CancerAtypical Endometrial Hyperplasia+3 more
Mayo Clinic 3,110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078838
What this trial is testing

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Intraepithelial NeoplasiaGrade 1 Endometrial Endometrioid Carcinoma
UNC Lineberger Comprehensive Cancer Center 40
Not applicableLooking for participantsNCT07077876
What this trial is testing

Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

Who this might be right for
Endometrial AdenocarcinomaEndometrial HyperplasiaFertility Preservation+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT00483327
What this trial is testing

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

Who this might be right for
Atypical Endometrial HyperplasiaEndometrial Carcinoma
NYU Langone Health 31
Not applicableLooking for participantsNCT04839614
What this trial is testing

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

Who this might be right for
Endometrial CarcinomaObesityEIN+2 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT00003179
What this trial is testing

Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 360
Not applicableLooking for participantsNCT04008563
What this trial is testing

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

Who this might be right for
Endometrial CancerAtypical HyperplasiaBariatric Surgery Candidate
University Health Network, Toronto 36
Not applicableLooking for participantsNCT04362046
What this trial is testing

Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

Who this might be right for
Endometrial HyperplasiaEndometrial CancerGynecologic Cancer
Vancouver Coastal Health Research Institute 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00788671
What this trial is testing

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Looking for participantsNCT05903131
What this trial is testing

Uterine Preservation Via Lifestyle Transformation

Who this might be right for
Endometrial HyperplasiaGrade 1 Endometrial Cancer
Washington University School of Medicine 96
Large-scale testing (Phase 3)Looking for participantsNCT05316935
What this trial is testing

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Who this might be right for
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance
Xiaojun Chen 80
Not applicableLooking for participantsNCT05647109
What this trial is testing

Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

Who this might be right for
Endometrial Carcinoma Stage IAtypical Endometrial Hyperplasia
Peking University People's Hospital 244
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686126
What this trial is testing

Improving the Treatment for Women With Early Stage Cancer of the Uterus

Who this might be right for
Complex Endometrial Hyperplasia With AtypiaGrade 1 Endometrial Endometrioid Adenocarcinoma
Queensland Centre for Gynaecological Cancer 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07349641
What this trial is testing

Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Who this might be right for
Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial NeoplasiaFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Looking for participantsNCT06379113
What this trial is testing

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Who this might be right for
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance+1 more
Xiaojun Chen 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03671811
What this trial is testing

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

Who this might be right for
Atypical Endometrial HyperplasiaEndometrial Carcinoma
City of Hope Medical Center 44
Testing effectiveness (Phase 2)WithdrawnNCT05483023
What this trial is testing

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00566644
What this trial is testing

Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome

Who this might be right for
Endometrial CancerHereditary Non-polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)
St George's, University of London 600
Testing effectiveness (Phase 2)Study completedNCT02035787
What this trial is testing

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06102863
What this trial is testing

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Who this might be right for
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
Peking University People's Hospital 38
Load More Results